From July 1, 2021 to December 31, 2021, the company has repurchased 696,000 shares, representing 0.44% for CNY 23.83 million. With this, the company has completed the repurchase of 2,273,523 shares, representing 1.44% for CNY 79.31 million under the buyback announced on January 21, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.84 CNY | +1.22% | +2.54% | -21.64% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.64% | 645M | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- 603590 Stock
- News Beijing Konruns Pharmaceutical Co.,Ltd.
- Tranche Update on Beijing Konruns Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 21, 2021.